Partridge Juneth Joaquin, Lopreiato Joseph Onofrio, Latterich Martin, Indig Fred Eliezer
Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Mol Biol Cell. 2003 Oct;14(10):4221-9. doi: 10.1091/mbc.e03-02-0111. Epub 2003 Aug 22.
We report a novel nucleolar interaction between the AAA ATPase p97/VCP and the Werner protein (WRNp), a member of the RecQ helicase family. p97/VCP mediates several important cellular functions in eucaryotic cells, including membrane fusion of the endoplasmic reticulum and Golgi and ubiquitin-dependent protein degradation. Mutations in the WRN gene cause Werner syndrome, a genetic disorder characterized by premature onset of aging symptoms, a higher incidence of cancer, and a high susceptibility to DNA damage caused by topoisomerase inhibitors. We observed that both WRNp and valosin-containing protein (VCP) were present in the nucleoplasm and in nucleolar foci in mammalian cells and that WRNp and p97/VCP physically interacted in the nucleoli. Importantly, the nucleolar WRNp/VCP complex was dissociated by treatment with camptothecin, an inhibitor of topoisomerase I, whereas other WRNp-associated protein complexes, such as WRNp/Ku 80, were not dissociated by this drug. Because WRN syndrome cells are sensitive to topoisomerase inhibitors, these observations suggest that the VCP/WRNp interaction plays an important role in WRN biology. We propose a novel role for VCP in the DNA damage response pathway through modulation of WRNp availability.
我们报道了一种AAA型ATP酶p97/VCP与Werner蛋白(WRNp)之间新的核仁相互作用,WRNp是RecQ解旋酶家族的成员。p97/VCP介导真核细胞中的几种重要细胞功能,包括内质网和高尔基体的膜融合以及泛素依赖性蛋白降解。WRN基因的突变会导致Werner综合征,这是一种遗传性疾病,其特征为衰老症状提前出现、癌症发病率较高以及对拓扑异构酶抑制剂引起的DNA损伤高度敏感。我们观察到WRNp和含缬酪肽蛋白(VCP)在哺乳动物细胞的核质和核仁灶中均有存在,并且WRNp和p97/VCP在核仁中发生物理相互作用。重要的是,用拓扑异构酶I抑制剂喜树碱处理可使核仁中的WRNp/VCP复合物解离,而其他与WRNp相关的蛋白复合物,如WRNp/Ku 80,则不会被这种药物解离。由于Werner综合征细胞对拓扑异构酶抑制剂敏感,这些观察结果表明VCP/WRNp相互作用在WRN生物学中起重要作用。我们提出VCP通过调节WRNp的可用性在DNA损伤反应途径中发挥新作用。